98 results on '"Vincent, Loic"'
Search Results
2. 1223 Non-viral targeted knock-in of a KRAS G12D specific TCR, CD8αβ, and chimeric cytokine receptor in theTRAClocus outperforms lentiviral-based engineering of T cells
3. 355 Directing a high avidity KRAS G12D-specific TCR engineered with a CD8αβ co-receptor and chimeric cytokine receptor using non-viral knock-in enhances anti-tumor responses
4. Abstract A009: AFNT-111: A novel TCR-engineered T cell therapy targeting the oncogenic driver KRAS G12V
5. Supplementary Table S1 and Supplementary Figures S1-S4 from Concomitant Inhibition of PI3Kβ and BRAF or MEK in PTEN-Deficient/BRAF-Mutant Melanoma Treatment: Preclinical Assessment of SAR260301 Oral PI3Kβ-Selective Inhibitor
6. Data from Concomitant Inhibition of PI3Kβ and BRAF or MEK in PTEN-Deficient/BRAF-Mutant Melanoma Treatment: Preclinical Assessment of SAR260301 Oral PI3Kβ-Selective Inhibitor
7. A Compact Low-Power 28-nm FD-SOI CMOS 76–81 GHz Dual-Path Receiver With Phase Control for Automotive Applications
8. Nonintrusive Machine Learning-Based Yield Recovery and Performance Recentering for mm-Wave Power Amplifiers: A Two-Stage Class-A Power Amplifier Case Study
9. 244 AFNT-111, a safe and effective TCR-engineered T cell therapy targeting the oncogenic driver KRAS G12V mutation
10. Accurate Design Method for Millimeter Wave Distributed Amplifier Based on Four-Port Chain (ABCD) Matrix Model
11. 342 KRAS G12V T cell receptor-engineered T cells expressing the durability FAS-41BB switch receptor exhibit a potent, persistent, coordinated CD4/CD8 anti-tumor responsein vitroandin vivo
12. A Compact 28-nm FD-SOI CMOS 76–81 GHz Automotive Band Receiver Path with Accurate 0.2° Phase Control Resolution
13. Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)
14. A Millimeter-Wave Substrate Integrated Waveguide Filter in Si-BCB Technology
15. Design of Coupled Slow-Wave CPW Millimeter-Wave Bandpass Filter Beyond 100 GHz in 55-nm BiCMOS Technology
16. mm-Wave Through-Load Element for On-Wafer Measurement Applications
17. 120-GHz 2-bit reflection-type phase shifter based on PIN diodes switched-lines.
18. The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell death
19. High-Performance Compact Reflection-Type Phase Shifter operating at 2 GHz Using a Transdirectional Coupler
20. Design of mm-Wave Slow-Wave-Coupled Coplanar Waveguides
21. In Vivo-Restricted and Reversible Malignancy Induced by Human Herpesvirus-8 KSHV: A Cell and Animal Model of Virally Induced Kaposi's Sarcoma
22. Erratum to: Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)
23. MethylQuant: A Tool for Sensitive Validation of Enzyme-Mediated Protein Methylation Sites from Heavy-Methyl SILAC Data
24. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
25. Miniaturization of Transmission Lines: Meandered Slow-wave CPWs
26. A Nonintrusive Machine Learning-Based Test Methodology for Millimeter-Wave Integrated Circuits
27. Highly Tunable High-Q Inversion-Mode MOS Varactor in the 1–325-GHz Band
28. Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors
29. Vascular frontiers without borders: Multifaceted roles of platelet-derived growth factor (PDGF) in supporting postnatal angiogenesis and lymphangiogenesis
30. Essential roles for deubiquitination in Leishmania life cycle progression
31. The role of protein arginine methylation in T-lymphocyte activation
32. Erratum to: Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)
33. Preparation and optimization of new 4-(2-(indolin-1-yl)-2-oxoethyl)-2-morpholinothiazole-5-carboxylic acid and amide derivatives as potent and selective PI3Kβ inhibitors
34. AFNT-211: An FAS-41BB–enhanced TCR-T cell therapy with stem-like properties targeting KRAS G12V-expressing solid tumors.
35. Concomitant Inhibition of PI3Kβ and BRAF or MEK in PTEN-Deficient/BRAF-Mutant Melanoma Treatment: Preclinical Assessment of SAR260301 Oral PI3Kβ-Selective Inhibitor
36. Preparation and optimization of new 4-(morpholin-4-yl)-(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives as PI3Kβ inhibitors
37. Comparaison des effets de canaux courts entre les technologies MOSFET FDSOI et MOSFET bulk
38. Abstract B2: Switching to aflibercept treatment resulted in greater tumor responses than continuous bevacizumab treatment in patient-derived xenograft models of colorectal cancer.
39. Abstract A48: Anti-tumor activity of the MEK inhibitor pimasertib in combination with the PI3K/mTOR inhibitor SAR245409 in low-grade serous ovarian cancer
40. Abstract 3258: Discovery and characterization of SAR260301, a novel PI3Kβ-selective inhibitor in clinical development for the treatment of PTEN-deficient tumors .
41. Abstract 4638: Anti-tumor activity of pimasertib in combination with SAR245409 or SAR245408 in human primary colorectal cancer xenograft models bearing PI3K/KRas and KRas mutations.
42. Discovery and Optimization of New Benzimidazole- and Benzoxazole-Pyrimidone Selective PI3Kβ Inhibitors for the Treatment of Phosphatase and TENsin homologue (PTEN)-Deficient Cancers
43. Abstract C162: Influence of tumor genotype on aflibercept (VEGF Trap) antitumor activity in preclinical tumors.
44. Stromal Incorporation of VEGFR-1+, CD68+ and α-SMA+ Hemangiogenic Cells Correlates with Histologic Subtype in Non-Hodgkin’s Lymphoma.
45. Multimodular Analysis of Angiogenic Biomarkers in the Primary Treatment of Multiple Myeloma: Correlative Studies of the BiRD Trial.
46. Expression of Vascular Endothelial-Cadherin on Leukemic Cells Mediates Their Interaction with Vascular Endothelium.
47. Newly Discovered Polymorphism in the CD34+ Stem Cell Specific AC133-P1 Promoter Linked to Leukemias.
48. Discovery and Optimizationof New Benzimidazole- andBenzoxazole-Pyrimidone Selective PI3Kβ Inhibitors for the Treatmentof Phosphatase and TENsin homologue (PTEN)-Deficient Cancers.
49. In Vivo-Restricted and Reversible Malignancy Induced by Human Herpesvirus-8 KSHV: A Cell and Animal Model of Virally Induced Kaposi's Sarcoma
50. Stromal Incorporation of VEGFR-1+, CD68+and α-SMA+Hemangiogenic Cells Correlates with Histologic Subtype in Non-Hodgkin's Lymphoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.